Advertisement

Impaired Magnesium Status and Depression

  • Nicola VeroneseEmail author
  • Marco Solmi
Living reference work entry

Abstract

Magnesium (Mg) is an element present in everyday dietary plan of regular meals, but it has been shown that a large part of the population presents a low Mg status. Mg has a wide range of physiologic and protective functions within energy regulation and cellular, included neuronal, homeostasis. It obstacles excessive calcium flow into the cells, preventing cells’ death, has anti-inflammatory properties, antioxidant action, and interacts with serotonin, a central neurotransmitter involved in depression pathophysiology. Epidemiologic studies have shown that low Mg status is associated with increased frequency of depression, with both cross-sectional and longitudinal designs. Promising evidence has shown that Mg has antidepressant activity similar to imipramine, and that it can be a valid supplementation to antidepressants in treatment resistant depression. However, at the present state of the art too few and small studies have investigated the role of Mg among other therapeutic means in depression, and any conclusion about its utility in clinical practice cannot be drawn. Future research should shed a light on such an important field needing more evidence.

Keywords

Magnesium Hypomagnesemia Depression Depressive mood Neurology Psychiatry Glutamate NMDA Magnesium supplementation Epidemiology Animal experiments 

List of Abbreviations

BDNF

Brain-derived neurotrophic factor

Mg

Magnesium

NMDA

N-methyl-D-aspartate

RCT

Randomized controlled trial

RDA

Recommended daily allowance

SSRI

Selective serotonin reuptake inhibitors

References

  1. Alzheimer C (2012) Molecular and cellular biology of neuroprotection in the CNS. New York, NY: Springer Science & Business MediaGoogle Scholar
  2. Araujo Sampaio F, Monte Feitosa M, Hermes Sales C, Costa E, Silva DM, Climaco Cruz KJ, Oliveira FE, Colli C, Do Nascimento Marreiro D (2014) Influence of magnesium on biochemical parameters of iron and oxidative stress in patients with type 2 diabetes. Nutr Hosp 30:570–576PubMedGoogle Scholar
  3. Bambling M, Edwards SC, Hall S, Vitetta L (2017) A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested. Inflammopharmacology 25:271CrossRefPubMedGoogle Scholar
  4. Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F (2008) Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res 21:218–223PubMedGoogle Scholar
  5. Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW (2015) Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology 51:164–175CrossRefPubMedGoogle Scholar
  6. Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos AR, Rodrigues AL (2009) Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 33:235–242CrossRefPubMedGoogle Scholar
  7. Carl-Albrecht H (2010) Cerebrospinal fluid magnesium level in different neurological disorders. Neurosci Med 1:60CrossRefGoogle Scholar
  8. Cheungpasitporn W, Thongprayoon C, Mao MA, Srivali N, Ungprasert P, Varothai N, Sanguankeo A, Kittanamongkolchai W, Erickson SB (2015) Hypomagnesaemia linked to depression: a systematic review and meta-analysis. Intern Med J 45:436–440CrossRefPubMedGoogle Scholar
  9. Derom M-L, Sayón-Orea C, Martínez-Ortega JM, Martínez-González MA (2013) Magnesium and depression: a systematic review. Nutr Neurosci 16:191–206CrossRefPubMedGoogle Scholar
  10. Du J, Zhu M, Bao H, Li B, Dong Y, Xiao C, Zhang GY, Henter I, Rudorfer M, Vitiello B (2016) The role of nutrients in protecting mitochondrial function and neurotransmitter signaling: implications for the treatment of depression, PTSD, and suicidal behaviors. Crit Rev Food Sci Nutr 56:2560–2578CrossRefPubMedPubMedCentralGoogle Scholar
  11. Durlach J, Bac P, Yasui M, Strong MJ, Ota K, Verity MA (1997) Mechanisms of action on the nervous system in magnesium deficiency and dementia. In: Miner metal neurotoxicology. CRC Press, Boca Raton, pp 201–210Google Scholar
  12. Eby GA, Eby KL (2006) Rapid recovery from major depression using magnesium treatment. Med Hypotheses 67:362–370CrossRefPubMedGoogle Scholar
  13. Eby GA, Eby KL (2010) Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses 74:649–660CrossRefPubMedGoogle Scholar
  14. Golan H, Kashtuzki I, Hallak M, Sorokin Y, Huleihel M (2004) Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: partial protection by magnesium sulfate. J Neurosci Res 78:430–441CrossRefPubMedGoogle Scholar
  15. Heiden A, Frey R, Presslich O, Blasbichler T, Smetana R, Kasper S (1999) Treatment of severe mania with intravenous magnesium sulphate as a supplementary therapy. Psychiatry Res 89:239–246CrossRefPubMedGoogle Scholar
  16. Iseri LT, French JH (1984) Magnesium: nature’s physiologic calcium blocker. Am Heart J 108:188–193CrossRefPubMedGoogle Scholar
  17. Joffe RT, Levitt AJ, Young LT (1996) The thyroid, magnesium and calcium in major depression. Biol Psychiatry 40:428–429CrossRefPubMedGoogle Scholar
  18. Kohler CA, Freitas TH, Maes M, De Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M, Veronese N, Herrmann N, Raison CL, Miller BJ, Lanctot KL, Carvalho AF (2017) Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand 135:373CrossRefPubMedGoogle Scholar
  19. Kozielec T, Starobrat-Hermelin B (1997) Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 10:143–148PubMedGoogle Scholar
  20. Levine J, Stein D, Rapoport A, Kurtzman L (1999) High serum and cerebrospinal fluid Ca/Mg ratio in recently hospitalized acutely depressed patients. Neuropsychobiology 39:63–70CrossRefPubMedGoogle Scholar
  21. Mark LP, Prost RW, Ulmer JL, Smith MM, Daniels DL, Strottmann JM, Brown WD, Hacein-Bey L (2001) Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging. Am J Neuroradiol 22:1813–1824PubMedGoogle Scholar
  22. Mehdi S, Atlas SE, Qadir S, Musselman D, Goldberg S, Woolger JM, Corredor R, Abbas MH, Arosemena L, Caccamo S (2016) Double-blind, randomized crossover study of intravenous infusion of magnesium sulfate versus 5% dextrose on depressive symptoms in adults with treatment-resistant depression. Psychiatry Clin Neurosci. doi: 10.1111/pcn.12480
  23. Nechifor M (2008) Interactions between magnesium and psychotropic drugs. Magnes Res 21:97–100PubMedGoogle Scholar
  24. Nielsen FH (2014) Effects of magnesium depletion on inflammation in chronic disease. Curr Opin Clin Nutr Metab Care 17:525–530CrossRefPubMedGoogle Scholar
  25. Pearlstein T, Steiner M (2000) Non-antidepressant treatment of premenstrual syndrome. J Clin Psychiatry 61(Suppl 12):22–27PubMedGoogle Scholar
  26. Ruljancic N, Mihanovic M, Cepelak I, Bakliza A, Curkovic KD (2013) Platelet serotonin and magnesium concentrations in suicidal and non-suicidal depressed patients. Magnes Res 26:9–17PubMedGoogle Scholar
  27. Serefko A, Szopa A, Poleszak E (2016) Magnesium and depression. Magnes Res 29:112–119PubMedGoogle Scholar
  28. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H (2004) Magnesium-deficient diet alters depression-and anxiety-related behavior in mice – influence of desipramine and Hypericum perforatum extract. Neuropharmacology 47:1189–1197CrossRefPubMedGoogle Scholar
  29. Sobolevskii AI, Khodorov BI (2002) Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci Behav Physiol 32:157–171CrossRefPubMedGoogle Scholar
  30. Spasov AA, Iezhitsa IN, Kharitonova MV, Kravchenko MS (2007) Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet. Zhurnal vysshei nervnoi deiatelnosti imeni IP Pavlova 58:476–485Google Scholar
  31. Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez Kitchen CM, Funderburg N, Mesiano S, Bernstein HB (2012) Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol 188:6338–6346CrossRefPubMedGoogle Scholar
  32. Szewczyk B, Poleszak E, Sowa-Kucma M, Siwek M, Dudek D, Ryszewska-Pokrasniewicz B, Radziwon-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60:588–589PubMedGoogle Scholar
  33. Veronese N, Berton L, Carraro S, Bolzetta F, De Rui M, Perissinotto E, Toffanello ED, Bano G, Pizzato S, Miotto F, Coin A, Manzato E, Sergi G (2014) Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: a randomized controlled trial. Am J Clin Nutr 100:974–981CrossRefPubMedGoogle Scholar
  34. Veronese N, Zanforlini BM, Manzato E, Sergi G (2015a) Magnesium and healthy aging. Magnes Res 28:112–115PubMedGoogle Scholar
  35. Veronese N, Zurlo A, Solmi M, Luchini C, Trevisan C, Bano G, Manzato E, Sergi G, Rylander R (2015b) Magnesium status in Alzheimer’s disease: a systematic review. Am J Alzheimers Dis Other Demen 31:208–213CrossRefPubMedGoogle Scholar
  36. Veronese N, Watutantrige SF, Luchini C, Solmi M, Sartore G, Sergi G, Manzato E, Barbagallo M, Maggi S, Stubbs B (2016) Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr 70:1354–1359CrossRefPubMedGoogle Scholar
  37. Volpe SL (2013) Magnesium in disease prevention and overall health. Adv Nutr (Bethesda) 4:378S–383SCrossRefGoogle Scholar
  38. Whang R (1987) Magnesium deficiency: pathogenesis, prevalence, and clinical implications. Am J Med 82:24–29CrossRefPubMedGoogle Scholar
  39. Zheltova AA, Kharitonova MV, Iezhitsa IN, Spasov AA (2016) Magnesium deficiency and oxidative stress: an update. Biomedicine 6:20CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.National Research CouncilNeuroscience InstitutePadovaItaly
  2. 2.Institute for clinical Research and Education in Medicine (IREM)PadovaItaly
  3. 3.Department of NeuroscienceUniversity of PadovaPadovaItaly

Personalised recommendations